Purchase Order W81K0218P0302
Award Date 10/1/18
Potential Completion Date 9/30/19
Potential Value $232K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Emigration Canyon, UT 84108, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of the Army Medical Command awarded a firm-fixed price purchase order to Biofire Diagnostics LLC, a foreign-owned for-profit organization, on December 19, 2017 for the supply of a respiratory panel IVD test kit with 30 tests. The contract has a potential value of $3,044,790.00 and a completion date of September 30, 2020. No set-aside designation was used. Biofire Diagnostics LLC is a leading provider of syndromic infectious disease testing products and services to federal...
- This is a firm fixed-price purchase order contract awarded by the Department of the Army Medical Command to BioFire Diagnostics LLC, a foreign-owned for-profit organization, for $322,645.64. The contract is for the provision of FDA-approved respiratory, blood culture identification, and meningitis/encephalitis diagnostic panels using BioFire's FilmArray Torch multiplex PCR instrument. This award has a 12-month base period from March 25, 2020 to September 30, 2020, with two 12-month option...
- This is a firm-fixed price purchase order awarded by the U.S. Army Medical Command (MEDCOM) to Biofire Diagnostics LLC, a foreign-owned for-profit organization, for the supply of reagents for the Biofire FilmArray system. The award has a ceiling value of $911,174.06 and a completion date of September 30, 2018. Biofire Diagnostics LLC is a leading provider of syndromic infectious disease testing products and services to federal agencies, including the Department of Veterans Affairs, Defense...
- This firm-fixed-price purchase order was awarded to Biofire Diagnostics LLC by the Defense Health Agency to provide FDA-approved molecular diagnostic panels compatible with the BioFire Torch system. The $1,881,825.06 contract covers a base period through September 30, 2025 and includes respiratory, blood culture identification, and meningitis panels with specific pathogen targets. This requirement originated from a sources sought notice for Tripler Army Medical Center. The award does not have...
- This is a federal contract award from the Department of the Army Medical Command to Biofire Diagnostics LLC, a for-profit, foreign-owned biotech company, for the delivery of Respiratory Panel Kits. The contract has a firm fixed price of $665,402.10 and a completion date of September 30, 2020. No set-aside designation was used. Biofire Diagnostics LLC is a leader in syndromic infectious disease testing and has received numerous federal contract awards as a prime contractor to provide a variety of...
- On October 1, 2020, the Defense Health Agency awarded Biofire Diagnostics LLC a firm fixed-price purchase order valued at approximately $4.5 million for the provision of respiratory, gastrointestinal, meningitis, and blood culture identification assay panels to the Department of Pathology and Area Laboratory Services at Brooke Army Medical Center in Fort Sam Houston, Texas. The contract, which has no set-aside designation, extends through September 30, 2025, and includes adjustments in reagent...
- This is a firm fixed price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Biofire Diagnostics LLC, a foreign-owned for-profit organization, for the provision of BIOFIRE RP2.1 RESPIRATORY PANEL COVID-19 TESTING. The contract, which does not have a set-aside designation, has a potential value of $115,425.00 and a completion date of November 30, 2021. Biofire Diagnostics LLC is a leader in syndromic infectious disease testing and has...
- This purchase order, awarded to Biofire Diagnostics LLC on October 1, 2020, provides respiratory panel reagents for the Department of Pathology at Madigan Army Medical Center (MAMC) in support of molecular diagnostic testing capabilities. The contract, valued at $1.91M with a completion date of September 30, 2025, represents a firm fixed-price procurement issued without set-aside designation. The award originated from a Department of the Army Medical Command solicitation that sought polymerase...
- The Defense Health Agency awarded a firm-fixed-price purchase order to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company, to provide molecular diagnostic testing kits. The $242,760 contract has a completion date of September 30, 2022 and was not set aside for any particular business type. Biofire Diagnostics is a leader in syndromic infectious disease testing and has held numerous federal contracts to supply a range of testing products and services, including to the...
- This is a firm fixed-price purchase order contract awarded by the U.S. Army Medical Command (MEDCOM) to Biofire Diagnostics LLC, a biotech company specializing in infectious disease testing. The contract, valued at $123,101.50, is for the provision of a GI PANEL PN RFIT-ASY-0116 product. No set-aside designation was used. Biofire Diagnostics LLC is an experienced federal contractor, holding multiple indefinite delivery contracts and blanket purchase agreements with various agencies, including...